Clinical trial
Study Evaluating 2 Dosing Regimens Of TRU-015 In Rheumatoid Arthritis
NCT00634933
Study timeline
Study start (unknown)2008-03-01Date precision: month
Registry last updated2013-03-11
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Arthritis, Rheumatoidunresolved
Interventions
TRU-015DRUG
MethylprednisoloneDRUG · verified · RxNorm: methylprednisolone
PrednisoneDRUG · verified · RxNorm: prednisone
TRU-015DRUG
MethylprednisoloneDRUG · verified · RxNorm: methylprednisolone
PrednisoneDRUG · verified · RxNorm: prednisone
TRU-015DRUG
MethylprednisoloneDRUG · verified · RxNorm: methylprednisolone
PrednisoneDRUG · verified · RxNorm: prednisone
Sponsors & collaborators
Pfizerlead sponsor
Mapped research locations
GuadalajaraJalisco, Mexico4Los AngelesCalifornia, United States2BucharestRomania2WorcesterMassachusetts, United States2WürzburgGermany2ChicagoIllinois, United States1DallasTexas, United States1St LouisMissouri, United States1San AntonioTexas, United States1ParisFrance1BirminghamAlabama, United States1CincinnatiOhio, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00634933 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.